scholarly article | Q13442814 |
P50 | author | Thor G. Theander | Q54802168 |
Ali Salanti | Q55174835 | ||
Caroline Pehrson | Q55176196 | ||
Mads Daugaard | Q55187252 | ||
Charlotte Spliid | Q56440960 | ||
Sam Mbulaiteye | Q57897111 | ||
Leona W. Ayers | Q120908498 | ||
Morten Agertoug Nielsen | Q44227553 | ||
P2093 | author name string | Giovanna Tosato | |
Steven J Reynolds | |||
Kishor Bhatia | |||
Sheeja T Pullarkat | |||
Francis Nkrumah | |||
Janet Neequaye | |||
Robert J Biggar | |||
Htoo Zarni Oo | |||
Thomas M Clausen | |||
Jamie R Rich | |||
Marina A Pereira | |||
Mette Ø Agerbaek | |||
Vincent Fung | |||
P2860 | cites work | Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy | Q24631961 |
Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study | Q33344450 | ||
Functional antibodies against VAR2CSA in nonpregnant populations from colombia exposed to Plasmodium falciparum and Plasmodium vivax | Q33603038 | ||
Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies | Q34095324 | ||
Evidence for the involvement of VAR2CSA in pregnancy-associated malaria | Q34364093 | ||
Plasmodium falciparum parasites expressing pregnancy-specific variant surface antigens adhere strongly to the choriocarcinoma cell line BeWo | Q34602087 | ||
The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site | Q35088554 | ||
Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana | Q35199289 | ||
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells | Q35558089 | ||
Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer | Q35832351 | ||
Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria | Q47232540 | ||
Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. | Q47871002 | ||
Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator | Q48034459 | ||
Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. | Q53636101 | ||
What is Burkitt's lymphoma and when is it endemic? | Q77361942 | ||
A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls? | Q35887785 | ||
TLRs innate immunereceptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1α-driven human polyclonal B-cell activation | Q36121797 | ||
The proteoglycan repertoire of lymphoid cells | Q36208202 | ||
Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns | Q36374795 | ||
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein | Q36683860 | ||
Chondroitin sulfate as a key molecule in the development of atherosclerosis and cancer progression | Q36713856 | ||
Chondroitin sulfate proteoglycans in tumor progression | Q36713861 | ||
Epidemiology and burden of malaria in pregnancy | Q36717617 | ||
Proteoglycans and their roles in brain cancer | Q36816444 | ||
Malaria in urban and rural areas of southern Ghana: A survey of parasitaemia, antibodies, and antimalarial practices. | Q36875777 | ||
CD74: a new candidate target for the immunotherapy of B-cell neoplasms | Q36944401 | ||
Endemic Burkitt lymphoma is associated with strength and diversity of Plasmodium falciparum malaria stage-specific antigen antibody response | Q37065688 | ||
Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area | Q37269963 | ||
Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility. | Q37470684 | ||
Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus | Q37629229 | ||
CSPG4 in cancer: multiple roles | Q37747536 | ||
Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification | Q37967337 | ||
Glycosaminoglycans: key players in cancer cell biology and treatment | Q37983930 | ||
Biosynthesis and function of chondroitin sulfate | Q38115113 | ||
Epstein-Barr virus latency: current and future perspectives | Q38603533 | ||
Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines. | Q38822694 | ||
International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years | Q38856922 | ||
Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda | Q38877214 | ||
Clinical features of Burkitt's lymphoma: The African experience | Q38892031 | ||
AN IMPROVED MAP FOR THE STUDY OF BURKITT'S LYMPHOMA SYNDROME IN AFRICA | Q39039962 | ||
Circulating Epstein-Barr virus-carrying B cells in acute malaria | Q39158105 | ||
Etiology of Burkitt's lymphoma--an alternative hypothesis to a vectored virus | Q39890720 | ||
Plasmodium falciparum: VAR2CSA expressed during pregnancy-associated malaria is partially resistant to proteolytic cleavage by trypsin | Q40144118 | ||
Targeting of CD44 eradicates human acute myeloid leukemic stem cells | Q40228130 | ||
Effective therapy of human lymphoma xenografts with a novel recombinant ribonuclease/anti-CD74 humanized IgG4 antibody immunotoxin | Q40383626 | ||
Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation | Q40512480 | ||
Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma | Q40635674 | ||
Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma | Q40981383 | ||
Serum immunoglobulin levels and malaria antibodies in Burkitt's lymphoma | Q41041966 | ||
Sickle cell trait, hemoglobin C trait, and Burkitt's lymphoma. | Q41060571 | ||
Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. | Q41919160 | ||
Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta | Q45249046 | ||
Antibodies among men and children to placental-binding Plasmodium falciparum-infected erythrocytes that express var2csa. | Q46337040 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | malaria | Q12156 |
Burkitt lymphoma | Q1016605 | ||
P304 | page(s) | 1597-1608 | |
P577 | publication date | 2017-02-06 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration | |
P478 | volume | 140 |
Q64360526 | Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies |
Q92988701 | Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein |
Q64105045 | From "Serum Sickness" to "Xenosialitis": Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc |
Q56119780 | The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner |
Search more.